Linezolid: A Review of its Use in the Management of Serious Gram-Positive Infections

ISSN： 0012-6667

Source： Drugs, Vol.61, Iss.4, 2001-01, pp. : 525-551

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Linezolid: A Pharmacoeconomic Review of its Use in Serious Gram-Positive Infections

By Plosker Greg L. Figgitt David P.

PharmacoEconomics, Vol. 23, Iss. 9, 2005-01 ,pp. : 945-964

Adis International

Access to resources Recommend Favorite

Quinupristin/Dalfopristin: A Review of its Use in the Management of Serious Gram-Positive Infections

By Lamb H.M. Figgitt D.P. Faulds D.

Drugs, Vol. 58, Iss. 6, 1999-12 ,pp. : 1061-1097

Adis International

Access to resources Recommend Favorite

Benefit-Risk Assessment of Linezolid for Serious Gram-Positive Bacterial Infections

By Falagas Matthew E. Vardakas Konstantinos Z.

Drug Safety, Vol. 31, Iss. 9, 2008-01 ,pp. : 753-768

Adis International

Access to resources Recommend Favorite

Linezolid: In Infants and Children with Severe Gram-Positive Infections

By Lyseng-Williamson K.A. Goa K.L.

Pediatric Drugs, Vol. 5, Iss. 6, 2003-01 ,pp. : 419-429

Adis International

Access to resources Recommend Favorite

Telavancin: a novel lipoglycopeptide for serious Gram-positive infections

By Laohavaleeson Somvadee Kuti Joseph L Nicolau David P

Expert Opinion on Investigational Drugs, Vol. 16, Iss. 3, 2007-03 ,pp. : 347-357

Informa Healthcare

Access to resources Recommend Favorite